Company intelligence / Profile preview

MMeditech

Bat-Yam, Israel

Ownership: Private
Development stage: Other

Overview

Meditec (Sam-On) is an Israeli family-owned pharmaceutical company that develops, manufactures, and markets Rx/OTC pharmaceuticals, nutritional supplements, and medical devices. They have over 50 registered products with unique formulations, including natural/herbal ingredients, and operate GMP, ISO 9001, and ISO 13485 approved facilities.

Modalities: Small MoleculesNutraceuticalsMedical Devices
Industry: Biotech

Drug pipeline

1 asset

TRICARDIA

Unknown

Beyond the preview

Go deeper on MMeditech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MMeditech.

Explore the full profile